| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_RP5-1101C3.1_0000100 | Intergenic-Exon | chr7:121961266-121994470 | chr7:122321212-122354416 | 98 nt | 0.5918 |
| hsa_RP5-1101C3.1_0000200 | Intergenic-Exon | chr7:121961266-122008258 | chr7:122321212-122368204 | 135 nt | 0.5111 |
| hsa_RP5-1101C3.1_0000300 | Intron-Intron | chr7:122021466-122022201 | chr7:122381412-122382147 | 736 nt | 0.3655 |
| hsa_RP5-1101C3.1_0000400 | Intergenic-Intron | chr7:122058160-122073552 | chr7:122418106-122433498 | 250 nt | 0.3600 |
| hsa_RP5-1101C3.1_0000500 | Intron-Intron | chr7:122065178-122065410 | chr7:122425124-122425356 | 233 nt | 0.4635 |
| hsa_CADPS2_0000100 | Exon-Intron | chr7:121959793-121969591 | chr7:122319739-122329537 | 198 nt | 0.4949 |
| hsa_chr7_0099300 | Intergenic-Intergenic | chr7:121959969-121960187 | chr7:122319915-122320133 | 219 nt | 0.3014 |
| hsa_CADPS2_0000200 | Exon-Exon | chr7:121960341-122076434 | chr7:122320287-122436380 | 73 nt | 0.4795 |
| hsa_CADPS2_0000600 | Exon-Exon | chr7:121965531-122019496 | chr7:122325477-122379442 | 288 nt | 0.3681 |
| hsa_CADPS2_0000700 | Exon-Exon | chr7:121965531-122028792 | chr7:122325477-122388738 | 320 nt | 0.3938 |
A review of studies in humans, mice, and rats indicates that the circCADPS2 demonstrates stable expression in myocardial tissue and body fluids, with specific expression patterns associated with sudden cardiac death-related diseases [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circCADPS2 as a top up-regulated circular RNA (fold change 17.62) in brain injury tissues compared to adjacent contusion tissues, with its increased expression validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].